Soluble E-Cadherin as a Potential Biomarker in Hereditary Diffuse Gastric Cancer Syndrome

Ann Surg Oncol. 2022 Dec;29(13):7955-7957. doi: 10.1245/s10434-022-12288-4. Epub 2022 Jul 26.

Authors

Martha E Teke¹, Lauren A Gamble¹, Sarah G Samaranayake¹, Benjamin L Green¹, Areeba Saif¹, Jonathan M Hernandez¹, Jeremy L Davis²

Affiliations

¹ Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
² Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. jeremy.davis@nih.gov.

PMID: 35882695
DOI: 10.1245/s10434-022-12288-4

No abstract available

Publication types

Letter

MeSH terms

Adenocarcinoma*
Biomarkers
Cadherins / genetics
Genetic Predisposition to Disease
Germ-Line Mutation
Humans
Stomach Neoplasms* / genetics

Substances

Cadherins
Biomarkers